A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Sep 2016
At a glance
- Drugs ReN 001 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms PISCES II
- Sponsors ReNeuron
- 13 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 21 Jun 2016 Planned number of patients changed from 41 to 21.
- 09 Oct 2015 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017, according to ClinicalTrials.gov record.